Market Tracker

01/30 6:05pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

During the Trading Day
41.55 -0.45 / -1.07%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
41.55 0.00 / 0.00%
 
Volume: 41.7K

Today’s Trading

Previous close42.00
Today’s open41.85
Day’s range41.36 - 42.97
Volume750,444
Average volume (3 months)515,964
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)+37.30%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio74.2
Price/Sales3.49
Price/Book3.90

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...-1.73-3.49%
LCILannett Company Inc-2.68-5.35%
CBPOChina Biologic Produ...+0.23+0.34%
RAREUltragenyx Pharmaceu...+0.10+0.17%
Data as of 4:00pm ET, 01/30/2015

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)$0.12
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts